| P50 | author | Marc Pouliot | Q55172332 |
| | Halima Rakhila | Q95946101 |
| P2093 | author name string | Ali Akoum | |
| | Nathalie Bourcier | |
| P2860 | cites work | Clinical practice. Endometriosis | Q24625416 |
| | Soluble human IL-1 receptor type 2 inhibits ectopic endometrial tissue implantation and growth: identification of a novel potential target for endometriosis treatment | Q47330590 |
| | Effects of prostaglandin E2 and vascular endothelial growth factor on sperm might lead to endometriosis-associated infertility | Q48690673 |
| | Intrauterine inhibition of prostaglandin transporter protein blocks release of luteolytic PGF2alpha pulses without suppressing endometrial expression of estradiol or oxytocin receptor in ruminants. | Q50915134 |
| | The multidrug resistance-associated protein 4 (MRP4) appears as a functional carrier of prostaglandins regulated by oxytocin in the bovine endometrium. | Q51403331 |
| | Major roles of prostanoid receptors IP and EP3 in endotoxin-induced enhancement of pain perception11Abbreviations:, prostaglandin E receptor subtype 1; IP, prostaglandin I receptor; LPS, lipopolysaccharide; and WT, wild-type mice | Q57613937 |
| | Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity | Q59072840 |
| | The concentrations of prostaglandins in endometrium during the menstrual cycle in women with measured menstrual blood loss | Q68738695 |
| | Peritoneal fluid prostaglandins in patients with endometriosis | Q69467213 |
| | Peritoneal fluid prostaglandins in various stages of the menstrual cycle: role in infertile patients with endometriosis | Q69871521 |
| | Peritoneal fluid prostaglandins and prostanoids in women with endometriosis, chronic pelvic inflammatory disease, and pelvic pain | Q70320045 |
| | [Blood levels of prostaglandins in fertile women and in women with different variants of endocrine infertility] | Q70623234 |
| | Involvement of prostaglandins in vasopressin stimulation of the human uterus | Q70900645 |
| | Etiology of infertility in monkeys with endometriosis: measurement of peritoneal fluid prostaglandins | Q70959987 |
| | Peritoneal fluid 6-keto-prostaglandin F1 alpha, thromboxane B2 in endometriosis and unexplained infertility | Q70962964 |
| | Endometrial and myometrial prostaglandin release during the menstrual cycle in relation to menstrual blood loss | Q71301257 |
| | Secretion of monocyte chemotactic protein-1 by cytokine-stimulated endometrial cells of women with endometriosis. Le groupe d'investigation en gynécologie | Q72509453 |
| | Peritoneal fluid prostaglandins in endometriosis, tubal disorders, and unexplained infertility | Q72813293 |
| | Identification of macrophage migration inhibitory factor as a potent endothelial cell growth-promoting agent released by ectopic human endometrial cells | Q73336708 |
| | Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis | Q73562927 |
| | Expression of human prostaglandin transporter in the human endometrium across the menstrual cycle | Q81290078 |
| | Expression of prostaglandin transporter in the bovine uterus and fetal membranes during pregnancy | Q81622252 |
| | [Expression of cylooxygenase-2 in endometriosis] | Q81714877 |
| | Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endometriotic epithelial and stromal cells through suppression of metalloproteinases | Q82634195 |
| | Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: involvement of novel kinase signaling pathways | Q24656185 |
| | Genetic and pharmacological analysis of prostanoid receptor function | Q28186062 |
| | Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice | Q28365869 |
| | Augmented epithelial multidrug resistance–associated protein 4 expression in peritoneal endometriosis: regulation by lipoxin A4 | Q29541818 |
| | Prostanoid receptors: structures, properties, and functions | Q29618426 |
| | Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanisms | Q33581564 |
| | PGF2α-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer. | Q33692377 |
| | Inactivating mutation in the prostaglandin transporter gene, SLCO2A1, associated with familial digital clubbing, colon neoplasia, and NSAID resistance | Q34017114 |
| | The prostaglandin transporter PGT transports PGH(2). | Q34106984 |
| | Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes | Q34203305 |
| | Expression, localization, and signaling of prostaglandin F2 alpha receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signaling pathways | Q34295017 |
| | Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation | Q34606100 |
| | Regulation of prostaglandin transporters in colorectal neoplasia | Q34920230 |
| | Lipoxin A₄ prevents the progression of de novo and established endometriosis in a mouse model by attenuating prostaglandin E₂ production and estrogen signaling | Q35107985 |
| | Prostaglandin E2 induces fibroblast growth factor 9 via EP3-dependent protein kinase Cdelta and Elk-1 signaling | Q35131505 |
| | JNK suppression is essential for 17β-Estradiol inhibits prostaglandin E2-Induced uPA and MMP-9 expressions and cell migration in human LoVo colon cancer cells. | Q35232048 |
| | Prostaglandin receptor signalling and function in human endometrial pathology. | Q35893894 |
| | The peritoneal environment in endometriosis | Q36045621 |
| | Prostaglandin receptors are mediators of vascular function in endometrial pathologies. | Q36479424 |
| | Molecular cloning and expression of a cDNA of the bovine prostaglandin F2 alpha receptor | Q36673901 |
| | Endometriosis: disease pathophysiology and the role of prostaglandins | Q36709685 |
| | Prostaglandins, pain, and inflammation | Q39504608 |
| | Endogenous Prostaglandins in Dysmenorrhea and the Effect of Prostaglandin Synthetase Inhibitors (PGSI) on Uterine Contractility | Q39674674 |
| | Selective blockade of prostaglandin E2 receptors EP2 and EP4 signaling inhibits proliferation of human endometriotic epithelial cells and stromal cells through distinct cell cycle arrest | Q39731516 |
| | Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer | Q39963201 |
| | Activation of FP prostanoid receptor isoforms leads to Rho-mediated changes in cell morphology and in the cell cytoskeleton | Q40914056 |
| | Prostaglandins: in pain and inflammations | Q41341188 |
| | Studies in the involvement of prostaglandins in uterine symptomatology and pathology | Q42116443 |
| | Prostaglandin F2alpha differentially affects mRNA expression relating to angiogenesis, vasoactivation and prostaglandins in the early and mid corpus luteum in the cow. | Q43059311 |
| | Prostaglandin E2 increases growth and motility of colorectal carcinoma cells | Q43559615 |
| | Endogenous prostaglandins and angiogenesis | Q43598415 |
| | Expression, localization, and signaling of PGE(2) and EP2/EP4 receptors in human nonpregnant endometrium across the menstrual cycle | Q43732477 |
| | Expression of COX-2 and PGE synthase and synthesis of PGE(2)in endometrial adenocarcinoma: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors | Q43760841 |
| | Matrix metalloproteinase (MMP)-2 and MMP-9 and their inhibitor, TIMP-1, in human term decidua and fetal membranes: the effect of prostaglandin F(2alpha) and indomethacin | Q43806698 |
| | Identification of multiple and distinct defects in prostaglandin biosynthetic pathways in eutopic and ectopic endometrium of women with endometriosis | Q44219919 |
| | Molecular cloning and characterization of bovine prostaglandin E2 receptors EP2 and EP4: expression and regulation in endometrium and myometrium during the estrous cycle and early pregnancy | Q44480648 |
| | Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy | Q44488004 |
| | Thromboxane prostanoid receptor in human airway smooth muscle cells: a relevant role in proliferation. | Q44551653 |
| | Effect of interferon-tau on prostaglandin biosynthesis, transport, and signaling at the time of maternal recognition of pregnancy in cattle: evidence of polycrine actions of prostaglandin E2. | Q45016603 |
| | Cyclooxygenase-2 regulates survival, migration, and invasion of human endometriotic cells through multiple mechanisms | Q46881298 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endometriosis | Q205764 |
| P304 | page(s) | 808146 | |
| P577 | publication date | 2015-07-09 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | Abnormal Expression of Prostaglandins E2 and F2α Receptors and Transporters in Patients with Endometriosis | |
| P478 | volume | 2015 | |